An international task force has developed standards for tracking outcome measures of patients with heart valve disease, a condition which is expected to double in prevalence by 2040. The standards were published Feb. 17 in Circulation: Cardiovascular Quality & Outcomes.
The Latest
An AI-powered patient screening tool helped heart failure researchers at Mass General Brigham cut down on the time required to screen patients for clinical trial eligibility, according to a study published Feb. 17 in JAMA.
Cardiology experts highlighted the increase of opportunities with the field of interventional heart failure, advocating for more standardized training pathways in the subspeciality, according to a comprehensive review published Feb. 10 in Journal of the Society for Cardiovascular Angiography and…
Cardiology experts highlighted the increase of opportunities with the field of interventional heart failure, advocating for more standardized training pathways in the subspeciality, according to a comprehensive review published Feb. 10 in Journal of the Society for Cardiovascular Angiography and…
A team at New York City-based NYU Langone successfully implanted the world's smallest pacemaker into a newborn baby suffering from a congenital complete heart block.
Philadelphia-based Jefferson Health has appointed Joseph Bavaria, MD, as executive director of the Bruce & Robbi Toll Heart and Vascular Institute and chair of the department of cardiac surgery at Thomas Jefferson University's Sidney Kimmel Medical College, also in Philadelphia.
On Feb. 14, Northwestern Health's Bluhm Cardiovascular Institute celebrated its 20th anniversary.
The utilization of virtual reality was found to decrease preoperative anxiety in older patients undergoing open-heart surgery, according to a study published Jan. 4 in Mayo Clinic Proceedings.
NYC Health + Hospitals/Elmhurst has opened a Women's Heart Health Institute to address gender disparities and care gaps found in women's cardiovascular healthcare.
Washington, D.C.-based Children's National Hospital has partnered with medical device company Compremium AG to help develop new technologies designed for pediatric patients. The partnership will first focus on noninvasive monitoring of central venous pressure for congenital heart disease patients.